Study

Slim Initiative in Genomic Medicine for the Americas (SIGMA): Diabetes in Mexico Study (DMS)

Study ID Alternative Stable ID Type
phs001388 Case-Control

Study Description

The ~52,000 sample Type 2 Diabetes Exome Sequencing project is a collaboration of six consortia with various funding mechanisms that have joined together to investigate genetic variants for type 2 diabetes (T2D) using the largest T2D case/control sample set compiled to date. This includes samples from:

  • Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES)
  • Genetics of Type 2 Diabetes (GoT2D)
  • Exome Sequencing Project (ESP)
  • Slim Initiative in Genomic Medicine for the Americas: Type 2 Diabetes (SIGMA T2D)
  • Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention, and Care (LuCAMP)
  • Progress in Diabetes Genetics in Youth (ProDIGY)

This data generated from the SIGMA Diabetes in Mexico Study (DMS) was part of the Slim Initiative in Genomic Medicine for the Americas: Type 2 Diabetes (SIGMA T2D), which is an international research consortium funded by the Carlos Slim Foundation that seeks to identify the genetic risk factors ... (Show More)

Archive Link Archive Accession
dbGaP phs001388

Who archives the data?

There are no publications available